The allegedly unfair behaviour of a competitor does not justify exclusionary practices against it
Cegedim, in a dominant position on the market of medical information databases intended for pharmaceutical laboratories, was heavily sanctioned by the French Competition Authority on 8 July 2014 for having implemented discriminatory practices against its competitor on the related market of client management software use for the pharmaceutical industry.
In this case, Cegedim was refusing to sell its database, called ‘One Key’, to laboratories using the management software commercialised by Euris, whereas it agreed to sell the database in question to those using competing software. This refusal was justified by the existence of a dispute for infringement initiated against Euris.
Following a complaint lodged by Euris, the authority first examined whether One Key was an essential infrastructure whose access should be granted to a competitor’s clients…
Click on the link below to read the rest of the Dentons briefing.
News from Dentons
News from The Lawyer
Briefings from Dentons
‘Inversion’ transactions are nothing new, and the current proceedings appear to be just another replay of earlier games of tag between the government and US multinationals.
In Devon Canada Corporation v The Queen, the issue is whether the taxpayer may deduct $20,884,041 paid to cancel issued stock options.
Analysis from The Lawyer
The continent’s boom in natural resources and renewable energy is sparking an infrastructure drive
Shearman & Sterling is making its presence felt in the City, squaring up to magic circle firms and looking to muscle in on key relationships. Private equity house Bridgepoint is one outfit that has had its head turned by the US firm.